Clinical significance of serum miR-31 as a predictive biomarker for lung adenocarcinoma
暂无分享,去创建一个
[1] Xiangkun Yuan,et al. miR‐297 acts as an oncogene by targeting GPC5 in lung adenocarcinoma , 2016, Cell proliferation.
[2] Shu-Chun Lin,et al. miR-31 targets ARID1A and enhances the oncogenicity and stemness of head and neck squamous cell carcinoma , 2016, Oncotarget.
[3] Guoqing Wang,et al. Downregulated miR-31 level associates with poor prognosis of gastric cancer and its restoration suppresses tumor cell malignant phenotypes by inhibiting E2F2 , 2016, Oncotarget.
[4] Rui Zhang,et al. MicroRNA-31 inhibits lung adenocarcinoma stem-like cells via down-regulation of MET-PI3K-Akt signaling pathway. , 2016, Anti-cancer agents in medicinal chemistry.
[5] G. Kong,et al. MicroRNA-432 functions as a tumor suppressor gene through targeting E2F3 and AXL in lung adenocarcinoma , 2016, Oncotarget.
[6] Zhongming Zhao,et al. MicroRNA-31 initiates lung tumorigenesis and promotes mutant KRAS-driven lung cancer. , 2015, The Journal of clinical investigation.
[7] I. Endo,et al. The potential role of microRNA‐31 expression in early colorectal cancer , 2015, Pathology international.
[8] Zhen Liu,et al. miR-31 functions as an oncogene in cervical cancer , 2015, Archives of Gynecology and Obstetrics.
[9] Suk Woo Nam,et al. MicroRNA-31 functions as a tumor suppressor by regulating cell cycle and epithelial-mesenchymal transition regulatory proteins in liver cancer , 2015, Oncotarget.
[10] K. Choy,et al. miR-31 is consistently inactivated in EBV-associated nasopharyngeal carcinoma and contributes to its tumorigenesis , 2014, Molecular Cancer.
[11] M. Boeri,et al. Potential biomarkers for lung cancer screening. , 2014, Translational lung cancer research.
[12] J. Zavadil,et al. Pro-tumorigenic Effects of miR-31 Loss in Mesothelioma* , 2010, The Journal of Biological Chemistry.
[13] Å. Borg,et al. MiRNA expression in urothelial carcinomas: Important roles of miR‐10a, miR‐222, miR‐125b, miR‐7 and miR‐452 for tumor stage and metastasis, and frequent homozygous losses of miR‐31 , 2009, International journal of cancer.
[14] L. Gaspar,et al. National survey of non-small cell lung cancer in the United States: epidemiology, pathology and patterns of care. , 2007, Lung cancer.
[15] X. Agirre,et al. MicroRNAs as cancer players: potential clinical and biological effects. , 2007, DNA and cell biology.
[16] J. Rehwinkel,et al. MicroRNAs silence gene expression by repressing protein expression and/or by promoting mRNA decay. , 2006, Cold Spring Harbor symposia on quantitative biology.
[17] Lin He,et al. MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature Reviews Genetics.